AN ORAL IRON (III) BASED PHOSPHATE ADSORBENT FOR TREATING IRON-DEFICIENCY ANEMIA IN CATS WITH CHRONIC KIDNEY DISEASEThe invention relates to the new use of an oral iron(III)-based phosphate adsorbent, for example SBR759, in the treatment of iron deficiency anaemia in cats with chronic kidney ...
Provided herein are also methods of treating cancer in an individual wherein cancer treatment comprises first administering to the individual an effective amount of a B-RAF inhibitor and second administering to the individual an effective amount of the B-RAF inhibitor and an effective amount of immu...
These can include: immune mediated hemolytic anemia, immune mediated skin disease, vaccine induced skin cancer in cats, skin allergies, arthritis, leukemia, inflammatory bowel disease and neurological conditions. It is more and more common to see cancer in dogs and cats under 5 years of age. ...
AN ORAL IRON (III) BASED PHOSPHATE ADSORBENT FOR TREATING IRON-DEFICIENCY ANEMIA IN CATS WITH CHRONIC KIDNEY DISEASEThe invention relates to the new use of an oral iron(III)-based phosphate adsorbent, for example SBR759, in the treatment of iron deficiency anaemia in cats with chronic kidney ...
ORAL IRON (III) BASED PHOSPHATE ADSORBENT FOR TREATING IRON-DEFICIENCY ANEMIA IN CATS WITH CHRONIC KIDNEY DISEASEThe invention relates to the new use of an oral iron(III)-based phosphate adsorbent, for example SBR759, in the treatment of iron deficiency anaemia in cats with chronic kidney ...